Emergent BioSolutions (EBS) Tops Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $7.26 -1.22%
Revenue Growth %: +32.0%
Financial Fact:
Income (loss) from operations: 35.48M
Today's EPS Names:
AQMS, HWBK, RJET, More
Revenue Growth %: +32.0%
Financial Fact:
Income (loss) from operations: 35.48M
Today's EPS Names:
AQMS, HWBK, RJET, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.18, $0.06 better than the analyst estimate of $0.12. Revenue for the quarter came in at $307.5 million versus the consensus estimate of $283.57 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ingram Micro Holding Corporation (INGM) Tops Q2 EPS by 4c
- Corteva (CTVA) Tops Q2 EPS by 8c; offers guidance
- Eversource Energy (ES) Misses Q2 EPS by 7c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
